JARRED UHRIG: Open Payments
NPI 1245839844 · KETTERING, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 39 payments from 7 companies in 2025. Trend: 2023 $273 · 2024 $306 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 24 | $185 |
| Amgen Inc. | 7 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| PFIZER INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: LEQVIO, REPATHA, JARDIANCE, CAMZYOS, VERQUVO, ELIQUIS, FARXIGA.
Industry payments across OH — which companies pay providers there.
